Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2028

Conditions
Multiple Sclerosis
Interventions
DEVICE

MS Sherpa

The MS Sherpa application is a CE-certified smartphone application (installed on the mobile phone of the patient) that collects digital biomarkers using tests (\~six minutes/test: self-monitoring questionnaires, smartphone 2-MWT, and a smartphone SDMT) once per week in the home environment of the patient.

DEVICE

Neurokeys

The NeuroKeys application is a CE-certified application (installed on the mobile phone of the patient) that passively and continuously monitors keystroke dynamics of everyday typing as a digital biomarker.

Trial Locations (3)

6815AD

Rijnstate Arnhem, Arnhem

6162BG

Zuyderland Medical Center, Geleen

1081HV

Amsterdam UMC, Amsterdam

All Listed Sponsors
lead

Amsterdam UMC, location VUmc

OTHER

NCT06627465 - Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis | Biotech Hunter | Biotech Hunter